Skye Bioscience, Inc. (SKYE): Net Income

Annual figures by period end, from SEC filings.

-$55.92M

Year ended 2025-12-31

-$50.49M

Trailing 12 months to 2026-06-30

2012-10-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$55.92M	n/m	2026-03-10, From 2025-01-01
2024-12-31	-$26.57M	n/m	2026-03-10, From 2024-01-01
2023-12-31	-$37.64M	n/m	2025-03-20, From 2023-01-01
2022-12-31	-$19.48M	n/m	2024-03-22, From 2022-01-01
2021-12-31	-$8.52M	n/m	2023-03-31, From 2021-01-01
2020-12-31	-$6.56M	n/m	2022-03-28, From 2020-01-01
2019-12-31	$1.05M	n/m	2021-03-02, From 2019-01-01
2018-12-31	-$19.19M	n/m	2020-03-23, From 2018-01-01
2017-12-31	-$3.09M	n/m	2019-03-14, From 2017-01-01
2016-12-31	-$3.18M	n/m	2018-03-19, From 2016-01-01
2015-12-31	-$4.84M	n/m	2017-03-10, From 2015-01-01
2014-12-31	-$2.73M	n/m	2016-03-21, From 2014-01-01
2013-12-31	-$120.4K	n/a	2015-03-27, From 2013-01-01
No annual figure between 2012-10-31 and 2013-12-31.
2012-10-31	$4.5K	n/a	2014-01-27, From 2011-11-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Skye Bioscience, Inc. (SKYE)	2025-12-31	-$55.92M	n/m
Biofrontera Inc. (BFRI)	2025-12-31	-$10.54M	n/m
Neuphoria Therapeutics Inc. (NEUP)	2026-06-30	-$13.45M	n/m
TuHURA Biosciences, Inc. (HURA)	2025-12-31	-$30.05M	n/m
Aptevo Therapeutics Inc. (APVO)	2025-12-31	-$25.97M	n/m
Talphera, Inc. (TLPH)	2025-12-31	-$14.29M	n/m
Veru Inc. (VERU)	2025-09-30	-$22.73M	n/m
Sol-Gel Technologies Ltd. (SLGL)	2025-12-31	-$6.13M	n/m
Sunshine Biopharma Inc. (SBFM)	2025-12-31	-$5.98M	n/m

Compare SKYE, BFRI, NEUP, HURA side by side · Screen every company in Pharmaceutical Preparations ↗